FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

IMMULITE RUBELLA QUANTITATIVE IGG, CATALOG # LKRBQ1 (100 TESTS), LKRBQ5 (500 TESTS)

K Number: K982078 · Decision Dec 11, 1998
Classifications
1
FEI Numbers
33
Registration Numbers
33
Same Product Code
93
Applicant Total
321
Review Days
179

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
IMMULITE RUBELLA QUANTITATIVE IGG, CATALOG # LKRBQ1 (100 TESTS), LKRBQ5 (500 TESTS)
K Number
K982078
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.3510
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Diagnostic Products Corp.
Date Received
June 15, 1998
Decision Date
December 11, 1998
Product Code
LFX
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LFX Enzyme Linked Immunoabsorbent Assay, Rubella

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LFX), ordered by most recent decision date.

View all

Other Clearances by Diagnostic Products Corp.

K Number Device Name
K063045 IMMULITE 2000, IMMULITE 2500 VANCOMYCIN
K034055 IMMULITE 2500 CK-MB, 2500 MYOGLOBIN, 2500 STAT TROPONIN I
K033234 IMMULITE 2500 AUTOMATED IMMUNOASSAY ANALYZER
K032881 IMMULITE/IMMULITE 1000 TOTAL TESTOSTERONE AND IMMULITE 2000 TOTAL TESTOSTERONE
K023152 IMMULITE 2000 ALLERGEN-SPECIFIC IGE
K023304 IMMULITE/IMMULITE 1000 CALCITONIN, MODEL LKCL AND IMMULITE 2000 CALCITONIN, MODEL L2KCL
K022603 IMMULITE 1000 AUTOMATED IMMUNOASSAY ANALYZER
K022118 IMMULITE TURBO CK-MB, MODELS LSKCP1 (100 TESTS), LSKCP5 (500 TESTS)
K021257 ANA LINE BLOT, CATALOG NUMBER: KALABI (20 TESTS)
K021208 IMMULITE 2000 MIXED ALLERGEN PANELS
Search all 321 clearances from Diagnostic Products Corp. →